IL11 and ischemic disease: We found that OGD may affect the IDO1/KYN metabolic pathway through IL11, thereby affecting fibroblast senescence and collagen expression, which may provide an effective basis for the treatment of cellular senescence caused by ischemic disease (Figure 11).